ChinaBio® Executive Workshop
You are invited to attend the “Building a Global Biotech Business in China” Executive Workshop as the guest of our hosts and sponsors: BioBay, Wilson Sonsini Goodrich & Rosati, Morrison & Foerster, Mingly China Growth Fund, ChinaBio®Accelerator, and ChinaBio® Today.
- The State of China Biotech
- Structuring A Global Life Science Company
- Building A Global Patent Portfolio
- Attracting Investment Capital
Join other key executives and managers of biotechnology and life science companies interested in learning how to leverage China to raise investment funds, develop new drugs or medical devices, and generate global intellectual property rights. Learn “how to do it” from our speakers who are all senior executives who have successfully put their principles into practice in the real world. Also meet other executives and managers from companies facing the same issues as you.
Greg B. Scott – President and Founder, ChinaBio® Accelerator
|Mr. Scott has helped launch over thirty life science startups in the US and China as a founder, investor and advisor. He founded the ChinaBio® Accelerator to help fund and mentor early stage life science companies in China. Mr. Scott is also the president and co-founder of Life Science Angels, and executive editor of ChinaBio® Today. Mr. Scott previously held senior management positions with PricewaterhouseCoopers, Capgemini and MCI.|
Wei Zhou, PhD, JD – Partner, Wilson Sonsini Goodrich & Rosati (WSGR)
|Dr. Wei Zhou is a partner at Wilson Sonsini Goodrich & Rosati, P.C., a leading law firm focusing on technology and growth company legal issues, where he focuses on corporate and intellectual property issues facing life sciences companies in the United States and China. Previously, he was the vice president of intellectual property and advanced technology at Affymetrix Inc. (Santa Clara, CA). Dr. Zhou obtained his JD from Stanford Law School and his PhD from Virginia Tech. He is also a graduate of the General Management Program at Harvard Business School.
Harris Gao, JD – Associate, Morrison & Foerster (MOFO)
|Harris Gao is an associate in the Shanghai office of Morrison & Foerster LLP, and handles the firm’s patent practice in China. His practice focuses on patent prosecution and patent litigation, and experienced with a variety of technologies, including computer, Cleantech, medical devices, chemical and pharmaceutical technologies. Mr. Gao received his BS in Applied Physics from Tsinghua University, his MS in Physics from Catholic University of America, and his JD from Columbia University. Mr. Gao is admitted to practice in New York, and before the United States Patent and Trademark Office.|
Yi Lin, PhD, MBA – Advisor, Mingly China Growth Fund
|Dr. Lin has extensive experience in life science and business operations. He co-founded Eastwin Life Sciences, which raised 10 million USD in venture capital in 2007, and previously worked for McKinsey & Company consulting. Dr. Lin received his MBA from Chicago University and his PhD in biology from Columbia University in New York after graduating from Peking University.|
This ChinaBio® Executive Workshop – Suzhou will be held at:
Auditorium A1 Building
218 Xinghu Rd
Suzhou Industrial Park, China
We would like to thank the following sponsors for making this event possible:
BioBay – BioBay, the fastest growing life science park in China, is located in the Suzhou Industrial Park (SIP), a cooperative program between China and Singapore. BioBay plays a key role as the innovation base for SIP to cultivate biotechnology industry and also an innovation platform for the biotechnology and nanotechnology development of both Suzhou city and China. www.biobay.com.cn
Wilson Sonsini Goodrich & Rosati – Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past four decades, Wilson Sonsini Goodrich & Rosati has established its reputation in life science by having an unmatched knowledge of and deep and long-standing contacts in the industry.www.wsgr.com
Morrison & Foerster – Morrison & Foerster’s Life Sciences Practice is comprised of more than 160 attorneys dedicated to serving life sciences companies, research institutions, and the venture capital funds and investments banks that finance them. Morrison & Foerster, a global law firm offering with offices in Shanghai, Beijing, and Hong Kong, as well as Tokyo, Europe and the United States, is uniquely positioned to assist life sciences entities around the world. www.mofo.com
Mingly China Growth Fund – Mingly China Growth Fund is a private equity fund formed in 2006 to make critical growth and expansion stage investments in China. The Fund Management Team and its Advisors include a collaboration of successful and experienced U.S. and Chinese investment professionals. Mingly brings: Demonstrated ability to identify sector leaders early and get closely engaged with founders; Deep and growing pipeline with active processes to monitor companies; Hands-on operating experience to help transform companies; Global network of contacts to assist with technology, sales and marketing and management expertise; and both Foreign Currency Fund and RMB Fund to meet the funding needs of various companies. www.mcgf.com.cn
ChinaBio® Today – ChinaBio® Today is an email and web newsletter focused on the rapidly evolving life science industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events. Free email subscriptions are available at www.ChinaBioToday.com.
About ChinaBio® Accelerator